Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0280801 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Dabesa Gobena und 17 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Emergency Management and Health Research Directorate, Oromia Health Bureau, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
COVID-19 pandemic caused by extended variants of SARS-CoV-2 has infected more than 350 million people, resulting in over 5.5 million deaths globally. However, the actual burden of the pandemic in Africa, particularly among children, remains largely unknown. We aimed to assess the seroepidemiological changes of SARS-CoV-2 infection after school reopening among school children in Oromia, Ethiopia.
Methods
A prospective cohort study involving students aged 10 years and older were used. A serological survey was performed twice, at school reopening in December 2020 and four months later in April 2021. Participants were selected from 60 schools located in 15 COVID-19 hotspot districts in Oromia Region. Serology tests were performed by Elecsys anti-SARS-CoV-2 nucleocapsid assay. Data were collected using CSentry CSProData Entry 7.2.1 and exported to STATA version 14.2 for data cleaning and analysis.
Results
A total of 1884 students were recruited at baseline, and 1271 completed the follow-up. SARS-CoV-2 seroprevalence almost doubled in four months from 25.7% at baseline to 46.3% in the second round, with a corresponding seroincidence of 1910 per 100,000 person-week. Seroincidence was found to be higher among secondary school students (grade 9–12) compared to primary school students (grade 4–8) (RR = 1.6, 95% CI 1.21–2.22) and among those with large family size (> = 5) than those with a family size of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Public Health Emergency Management and Health Research Directorate, Oromia Health Bureau, Addis Ababa, Ethiopia.
- School of Medical Laboratory Science, Institute of Health, Jimma University, Jimma, Ethiopia.
- Department of Internal Medicine, Jimma University, Jimma, Ethiopia.
- Fenot Project, School of Population and Public Health, University of British Columbia, Addis Ababa, Ethiopia.
- Armauer Hanssen Research Institute, Addis Ababa, Ethiopia.
- Department of Epidemiology, Jimma University, Jimma, Ethiopia.
ORCID-Profile: Dabesa Gobena, Tizta Tilahun Degfie
Zitieren
APA
Gobena, D., Kebede Gudina, E., Yilma, D., Girma, T., Gebre, G., Gelanew, T., Abdissa, A., Mulleta, D., Sarbessa, T., Asefa, H., Woldie, M., Shumi, G., Kenate, B., Kroidl, A., Wieser, A., Eshetu, B., Degfie, T. T., & Mekonnen, Z. (2023). Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study. PLOS ONE. https://doi.org/10.1371/journal.pone.0280801
Vancouver
Gobena D, Kebede Gudina E, Yilma D, Girma T, Gebre G, Gelanew T, et al. Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study. PLOS ONE. 2023. doi:10.1371/journal.pone.0280801
BibTeX
@article{Gobena2023,
author = {Gobena, Dabesa and Kebede Gudina, Esayas and Yilma, Daniel and Girma, Tsinuel and Gebre, Getu and Gelanew, Tesfaye and Abdissa, Alemseged and Mulleta, Daba and Sarbessa, Tarekegn and Asefa, Henok and Woldie, Mirkuzie and Shumi, Gemechu and Kenate, Birhanu and Kroidl, Arne and Wieser, Andreas and Eshetu, Beza and Degfie, Tizta Tilahun and Mekonnen, Zeleke},
title = {Escalating spread of SARS-CoV-2 infection after school reopening among students in hotspot districts of Oromia Region in Ethiopia: Longitudinal study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0280801}
}
EUVIMED